|Articles|May 2, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
  • Volume 10
  • Issue 5

Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

Author(s)Melanie Sena

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Johnson & Johnson reported its affiliate Janssen Pharmaceutical NV has entered into a collaboration with the Stiching International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health, to help improve overall public health.

More than 130 low- and middle-income countries outside of the US will now be able to obtain this new anti-tuberculosis medicine through the procurement processes of GDF and its agent, the IDA.

Source: Johnson & Johnson

Articles in this issue

almost 12 years ago

Using eClinical Systems for Supply-Chain Management

almost 12 years ago

FDA and Industry Take Action for a More Secure Drug Supply Chain

almost 12 years ago

Packaging Becomes Enabler for Biopharmaceuticals

almost 12 years ago

Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List

almost 12 years ago

Azzur Group and BioSPEQ Announce Merger

almost 12 years ago

Eli Lilly Launches Second Education Program for Medical Students

almost 12 years ago

Global Instability Impacts Brazil's Pharma Market

almost 12 years ago

US Biopharma Worries About Losing Lead in Innovation

almost 12 years ago

Outsourcing Remains Strong In Traditional Areas

almost 12 years ago

Process Design Is Critical for Commercial Manufacture of HPAPIs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content